You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/75024
Title: 
Pharmacogenomic approaches that may guide preeclampsia therapy
Author(s): 
Institution: 
  • Universidade de São Paulo (USP)
  • Universidade Estadual Paulista (UNESP)
ISSN: 
  • 1462-2416
  • 1744-8042
Issue Date: 
1-Apr-2013
Citation: 
Pharmacogenomics, v. 14, n. 6, p. 591-593, 2013.
Time Duration: 
591-593
Keywords: 
  • antihypertensive therapy
  • epigenetics
  • epistasis
  • pharmacogenomics
  • preeclampsia
  • atorvastatin
  • endoglin
  • hydralazine
  • labetalol
  • methyldopa
  • nifedipine
  • nitric oxide
  • vasculotropin receptor 1
  • CACNA1A gene
  • CYP3A5 gene
  • disease marker
  • DNA polymorphism
  • eNOS gene
  • FLT 1 gene
  • gene
  • human
  • MMP9 gene
  • personalized medicine
  • review
  • treatment outcome
  • VEGF gene
  • VEGFR 1 gene
  • VEGFR 2 gene
Source: 
http://dx.doi.org/10.2217/pgs.13.23
URI: 
Access Rights: 
Acesso restrito
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/75024
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.